Analyst firms · Piper Sandler · DOCS

Piper Sandler DOCS price target and rating history

Doximity Inc. (DOCS) · Technology

Piper Sandler rates Doximity Inc. (DOCS) Overweight with a $78 price target, as of its latest action on Feb 7, 2025. It has published 4 rating actions on DOCS since July 2021, including 1 upgrade and 1 downgrade. Across 12 firms with a DOCS price target in the last 12 months, the median target is $27.

Current rating
Overweight
Price target
$78
Median target, all firms
$27
Actions on DOCS
4

Piper Sandler price target on DOCS

$81$59$3620222023202420252026
Piper Sandler price target on DOCS, each point a stated target, July 2021 to February 2025.

Every Piper Sandler rating on DOCS

How other firms rate DOCS

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wells FargoUnderweight$18Aug 10, 2026
BofA SecuritiesUnderperform$20Jun 29, 2026
BarclaysEqual Weight$20May 15, 2026
KeyBanc Capital MarketsSector WeightMay 14, 2026
Robert W. BairdNeutral$18May 14, 2026
BTIGNeutralMay 14, 2026
JefferiesHold$19May 14, 2026
Truist SecuritiesHold$29Apr 20, 2026
Evercore ISIIn-line$25Apr 8, 2026
Canaccord GenuityBuy$34Feb 9, 2026
RBC Capital MarketsOutperform$59Jan 9, 2026
Morgan StanleyOverweight$65Dec 15, 2025
Raymond JamesStrong Buy$65Nov 21, 2025
BMO Capital MarketsMarket Perform$55Nov 13, 2025

Questions about Piper Sandler and DOCS

What is Piper Sandler's price target for DOCS?
Piper Sandler's latest stated price target for Doximity Inc. (DOCS) is $78, from its action on Feb 7, 2025.
What is Piper Sandler's rating on DOCS?
Piper Sandler rates DOCS Overweight, a bullish rating, as of Feb 7, 2025.
When did Piper Sandler last change its view on DOCS?
On Feb 7, 2025, Piper Sandler upgrades to Overweight from Neutral, price target $31 to $78.
How does Piper Sandler's DOCS target compare with other analysts?
Across 12 firms with a DOCS price target in the last 12 months, the median target is $27.

More DOCS rating histories

All Piper Sandler ratingsDOCS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.